Talk:Pashanabheda: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
Dridhabala (talk | contribs) No edit summary |
||
| Line 104: | Line 104: | ||
== Phytochemical Composition == | == Phytochemical Composition == | ||
Pashanabheda is currently placed in the genus ''Bergenia'' as ''Bergenia ligulata'' (Wall.) Engl., with ''Saxifraga ligulata'' Wall. as a synonym. Its rhizomes are rich in phenolic compounds. | |||
* ''' | |||
* '''Major phenolics:''' Bergenin (a C-glycoside of 4-O-methylgallic acid), arbutin, catechin, gallic acid, protocatechuic acid, chlorogenic acid, ferulic acid and syringic acid have been quantified in ''Bergenia'' rhizomes. Among the species studied, ''B. ligulata'' contained the highest amount of bergenin, the major marker compound.<ref name="Pandey2017">Pandey R, Kumar B, Meena B, Srivastava M, Mishra T, Tiwari V, et al. Major bioactive phenolics in ''Bergenia'' species from the Indian Himalayan region: method development, validation and quantitative estimation using UHPLC-QqQLIT-MS/MS. PLoS One. 2017;12(7):e0180950.</ref> | |||
* ''' | * '''Other isolated compounds:''' 11-O-p-hydroxybenzoylbergenin, 6-O-galloylarbutin and epiafzelechin were isolated from the ethyl acetate fraction of the methanolic extract, in addition to bergenin.<ref name="Rajbhandari2011">Rajbhandari M, Khatri HR, Lalk M, Gewali MB, Lindequist U. Phytochemical investigation and antibacterial activity of ''Bergenia ligulata''. J Nepal Chem Soc. 2011;28:110–114.</ref> | ||
== Pharmacological Activities & Therapeutic Efficacy == | == Pharmacological Activities & Therapeutic Efficacy == | ||
=== Anti-Urolithiatic and | === Anti-Urolithiatic, Lithotriptic and Diuretic Effects (Asmari) === | ||
Pashanabheda is | Pashanabheda is traditionally the foremost drug for urinary stones, and experimental work supports this use. | ||
* '''Mechanism:''' | * '''Mechanism:''' A crude aqueous-methanolic extract of the rhizome inhibited calcium oxalate crystal aggregation and crystal formation in metastable solutions, showed antioxidant activity (DPPH radical scavenging and lipid peroxidation), and produced diuresis with a saluretic effect in rats. | ||
* '''Scientific Evidence:''' | * '''Scientific Evidence:''' In rats given 0.75% ethylene glycol to induce urolithiasis, the extract (5–10 mg/kg) prevented calcium oxalate crystal deposition in the renal tubules. The authors attribute the effect to crystal inhibition, diuretic, hypermagnesuric and antioxidant actions.<ref name="Bashir2009">Bashir S, Gilani AH. Antiurolithic effect of ''Bergenia ligulata'' rhizome: an explanation of the underlying mechanisms. J Ethnopharmacol. 2009;122(1):106–116.</ref> | ||
=== | === Anti-Inflammatory and Antipyretic Effects (Mutrakriccha) === | ||
A review of the experimental literature reports that an oral 50% ethanolic extract of ''B. ligulata'' at 1 g/kg showed anti-inflammatory activity in Wistar rats, and a 500 mg/kg dose showed antipyretic activity against yeast-induced fever.<ref name="Roychoudhury2022">Roychoudhury S, et al. Clinical potential of Himalayan herb ''Bergenia ligulata'': an evidence-based study. Molecules. 2022;27(20):7039.</ref> This is a secondary source; controlled clinical studies of the effect on painful urination are lacking. | |||
=== | === Antibacterial Activity === | ||
The methanolic extract of ''Bergenia ligulata'' showed antibacterial activity against gram-positive bacteria in a screening of plant extracts, and bioassay-guided fractionation yielded bergenin and related phenolics.<ref name="Rajbhandari2011"/> | |||
== Safety | == Safety and Dosage == | ||
* '''Precautions:''' Consult a qualified Ayurvedic practitioner if managing large obstructive renal calculi that require surgical intervention. | * '''Precautions:''' Consult a qualified Ayurvedic practitioner if managing large obstructive renal calculi that require surgical intervention. | ||
* '''Standard Therapeutic Dosage:''' | * '''Standard Therapeutic Dosage:''' | ||
| Line 134: | Line 129: | ||
== Summary of Therapeutic Profile == | == Summary of Therapeutic Profile == | ||
{| class="wikitable sortable" style="text-align: left;" | {| class="wikitable sortable" style="text-align: left;" | ||
|+ Therapeutic Applications of ''Saxifraga ligulata'' | |+ Therapeutic Applications of ''Saxifraga ligulata'' (''Bergenia ligulata'') | ||
! Indication | ! Indication | ||
! | ! Preparation / Constituents Studied | ||
! Primary Pharmacological Action | ! Primary Pharmacological Action | ||
|- | |- | ||
| '''Renal Calculi / Asmari''' | | '''Renal Calculi / Asmari''' | ||
| | | Aqueous-methanolic rhizome extract | ||
| Anti-urolithiatic, | | Anti-urolithiatic, Diuretic, Antioxidant | ||
|- | |- | ||
| '''Dysuria / Mutrakriccha''' | | '''Dysuria / Mutrakriccha''' | ||
| | | 50% ethanolic extract | ||
| | | Anti-inflammatory, Antipyretic (animal studies) | ||
|- | |- | ||
| '''Urinary Tract Infections''' | | '''Urinary Tract Infections''' | ||
| | | Methanolic extract, bergenin and related phenolics | ||
| | | Antibacterial (gram-positive bacteria) | ||
|} | |} | ||
| Line 155: | Line 150: | ||
{{Reflist|refs= | {{Reflist|refs= | ||
<ref name="ref1">Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 1: 57.</ref> | <ref name="ref1">Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 1: 57.</ref> | ||
<ref name=" | <ref name="Pandey2017">Pandey R, Kumar B, Meena B, Srivastava M, Mishra T, Tiwari V, et al. Major bioactive phenolics in ''Bergenia'' species from the Indian Himalayan region: method development, validation and quantitative estimation using UHPLC-QqQLIT-MS/MS. PLoS One. 2017;12(7):e0180950.</ref> | ||
<ref name=" | <ref name="Rajbhandari2011">Rajbhandari M, Khatri HR, Lalk M, Gewali MB, Lindequist U. Phytochemical investigation and antibacterial activity of ''Bergenia ligulata''. J Nepal Chem Soc. 2011;28:110–114.</ref> | ||
<ref name=" | <ref name="Bashir2009">Bashir S, Gilani AH. Antiurolithic effect of ''Bergenia ligulata'' rhizome: an explanation of the underlying mechanisms. J Ethnopharmacol. 2009;122(1):106–116.</ref> | ||
<ref name="Roychoudhury2022">Roychoudhury S, et al. Clinical potential of Himalayan herb ''Bergenia ligulata'': an evidence-based study. Molecules. 2022;27(20):7039.</ref> | |||
}} | }} | ||
[[Index.php?title=Category:Database of herbs and minerals| Herbs]] | [[Index.php?title=Category:Database of herbs and minerals| Herbs]] | ||